Bluejay Diagnostics Reports 2022 Financial Results
20.03.2023 - ACTON, Mass., March 20, 2023 (GLOBE NEWSWIRE) - Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid tests using whole blood on its Symphony platform to improve patient outcomes in ...
United States Alexandra Schuman Exchange Commission American Association For Clinical Chemistry Bluejay Diagnostics Inc American Association
Source: wallstreet-online.de